Compiled by Rupeestop LLP, SEBI RIA INA000022701. NAV as on 19 Aug 2026. Factsheet Jun 2026. About · Disclosures
ITI Pharma and Healthcare Fund - Direct Plan - Growth
ITI Mutual FundSectoral Pharma and HealthcareDirectGrowthVery high risk
NAV
₹19.7621
As on 19 Aug 2026
Vs category
| Period | This fund | Category | Rank |
|---|---|---|---|
| 1 year | +11.71% | — | — |
| 3 year | +19.91% | — | — |
| 5 year | +15.34% | — | — |
- Sharpe
- 0.90
- Std dev
- 16.79%
- Beta
- 0.97
Returns
From NAVs through 19 Aug 2026
1Y
+11.71%
Total
3Y
+19.91%
p.a.
5Y
+15.34%
p.a.
SI
+15.34%
p.a.
Calendar years
-6.68%2022
+34.39%2023
+43.95%2024
-8.24%2025
+15.81%2026 YTD
Rolling 1-year · 45 overlapping windows
-7.27%avg +19.30%+61.91%
Fund facts
Fund details from the Jun 2026 factsheet
Fund size
₹251.87 Cr
Expense ratio
0.68%
Exit load
None
Lock-in
None
BenchmarkNIFTY Healthcare TRI
Launched11 Nov 2021
Risk levelVery high
StructureOpen Ended
ISININF00XX01BO9
Where the money is invested
Split by asset type.
By asset type
Equity98.01%
Cash1.99%
What the fund holds
41 holdings · portfolio as on 30 May 2026
- 14.25%Sun Pharmaceuticals Industries LtdHealthcare
- 8.43%Divi's Laboratories LtdHealthcare
- 6.2%Apollo Hospitals Enterprise LtdHealthcare
- 5.06%Laurus Labs LtdHealthcare
- 4.9%Torrent Pharmaceuticals LtdHealthcare
- 4.9%Max Healthcare Institute Ltd Ordinary SharesHealthcare
- 4.28%Aurobindo Pharma LtdHealthcare
- 3.98%Dr Reddy's Laboratories LtdHealthcare
- 3.53%Lupin LtdHealthcare
- 3.42%Cipla LtdHealthcare
Concentration
Top 5 weight
38.84%
Top 10 weight
58.94%
Avg turnover
43.33%
Risk and quality measures
How steady the returns have been.
Return quality
Sharpe
0.9
Below category avg 0.98
Sortino
1.23
Return per unit of downside risk
Alpha
-1.99
Return above the benchmark
Information ratio
-0.2
Consistency of outperformance
Risk
Std deviation
16.79%
How much returns swing
Beta
0.97
Below category avg 0.95
R-squared
96.6%
How closely it tracks the benchmark
Who manages this fund
3 fund managers
- DSDhimant Shah13.7 years in the industryRuns 17 schemes
- RBRajesh Bhatia2.5 years in the industryRuns 17 schemes
- RKRohan Korde4.8 years in the industryRuns 13 schemes
Other Sectoral Pharma and Healthcare funds
ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan Growth-InsureddirectCompare
HDFC Pharma and Healthcare Fund Direct Plan IDCW ReinvestmentdirectCompare- ICICI Prudential Pharma Healthcare and Diagnostics (p.h.d) Fund Direct Plan IDCW PayoutdirectCompare
Bandhan Healthcare FunddirectCompare- Bandhan BSE Healthcare Index Fund - Direct Plan - GrowthdirectCompare
DSP Nifty Healthcare ETF-Direct PlandirectCompare
Mirae Asset Nifty 500 Healthcare ETFdirectCompare
PGIM India Healthcare Fund Direct Plan - GrowthdirectCompare
SIP illustration
Rate
+19.91%
Invested
₹6,00,000
Illustrated
₹19,00,627
₹5,000/mo × 10 years at this fund's 3Y CAGR. Illustration, not a forecast. SIP calculator
Other versions
- directIDCWITI Pharma and Healthcare Fund - Direct Plan - IDCW ReinvestmentNAV ₹17.4077
- regularGrowthITI Pharma and Healthcare Fund - Regular Plan - GrowthNAV ₹16.0304
- regularIDCWITI Pharma and Healthcare Fund - Regular Plan - IDCW ReinvestmentNAV ₹16.0304
FAQ
What is ITI Pharma and Healthcare Fund - Direct Plan - Growth NAV today?
- The latest NAV of ITI Pharma and Healthcare Fund - Direct Plan - Growth is ₹19.7621 as on 19 Aug 2026.
How has ITI Pharma and Healthcare Fund - Direct Plan - Growth performed vs its category?
- 1-year return +11.71%. Past performance does not guarantee future returns.
What are the returns of ITI Pharma and Healthcare Fund - Direct Plan - Growth?
- Trailing returns from published NAVs: 1 year +11.71%, 3 year +19.91% a year, 5 year +15.34% a year, since our first NAV +15.34% a year. Past performance does not guarantee future returns.
How would a SIP in ITI Pharma and Healthcare Fund - Direct Plan - Growth have been illustrated?
- The SIP illustration on this page uses ₹5,000 a month for 10 years at this fund's 3-year annualised return of +19.91%. It is not a forecast.
What is the expense ratio and fund size of ITI Pharma and Healthcare Fund - Direct Plan - Growth?
- For ITI Pharma and Healthcare Fund - Direct Plan - Growth, the expense ratio is 0.68% and fund size (AUM) is ₹251.87 Cr.
What is the ISIN of ITI Pharma and Healthcare Fund - Direct Plan - Growth?
- The ISIN for ITI Pharma and Healthcare Fund - Direct Plan - Growth is INF00XX01BO9.
Mutual fund investments are subject to market risks. Read all scheme related documents carefully before investing. Past performance does not guarantee future returns and is not an indicator of future results.
Figures on this page come from published NAVs and the scheme's monthly factsheet. They are for information only and are not investment advice or a recommendation to buy or sell any scheme.